Utah firm Xlear Inc. responds to the Federal Trade Commission’s allegation that it doesn’t have substantiation to say its saline nasal spray formulation prevents and treats COVID-19 by arguing that it’s not making a health claim but referencing research showing efficacy for its product.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?